Medicare Enrolled
Dr. Mohammad Al-Ali, MD
Critical Care Medicine · Grand Blanc, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Al-Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Al-Ali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Al-Ali
Dr. Mohammad Al-Ali is a critical care medicine specialist in Grand Blanc, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Al-Ali performed 2,800 Medicare services across 1,655 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Ali received a total of $4,940 from 39 pharmaceutical and/or device companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Ali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in MI
$4,940 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,800
Medicare services
Top 7% in MI for critical care medicine
1,655
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~147 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
817 | $92 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
664 | $61 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
285 | $88 | $157 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
213 | $133 | $285 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
201 | $165 | $479 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
108 | $27 | $300 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
103 | $38 | $106 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
103 | $40 | $107 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
47 | $25 | $70 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
42 | $25 | $138 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $127 | $189 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
34 | $100 | $175 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
25 | $46 | $122 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
25 | $81 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $117 | $234 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
24 | $14 | $30 |
| New patient office visit, complex (60-74 min) | 16 | $159 | $272 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
15 | $64 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $55 | $117 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,940
Total received (2018-2024)
Avg $706/year across 7 years
Top 28% in MI for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
228
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,730 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$211 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$750
2023
$581
2022
$719
2021
$1,241
2020
$448
2019
$691
2018
$510
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$137
HARMONY BIOSCIENCES LLC
$96
AstraZeneca Pharmaceuticals LP
$94
GENZYME CORPORATION
$84
JAZZ PHARMACEUTICALS INC.
$73
Amgen Inc.
$61
Mylan Specialty L.P.
$41
Axsome Therapeutics, Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Resmed Corp
$19
Insmed, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$15
Gilead Sciences, Inc.
$14
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
Pulmonx Corporation
$974
AstraZeneca Pharmaceuticals LP
$516
GlaxoSmithKline, LLC.
$463
Boehringer Ingelheim Pharmaceuticals, Inc.
$307
Actelion Pharmaceuticals US, Inc.
$235
Genentech USA, Inc.
$218
JAZZ PHARMACEUTICALS INC.
$201
Mylan Specialty L.P.
$186
Insmed, Inc.
$182
GENZYME CORPORATION
$159
HARMONY BIOSCIENCES LLC
$126
Regeneron Healthcare Solutions, Inc.
$117
Novartis Pharmaceuticals Corporation
$104
Resmed Corp
$89
Axsome Therapeutics, Inc.
$87
United Therapeutics Corporation
$86
Takeda Pharmaceuticals U.S.A., Inc.
$80
Amgen Inc.
$78
CSL Behring
$74
Harmony Biosciences LLC
$73
Janssen Pharmaceuticals, Inc
$65
Gilead Sciences, Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$52
Teva Pharmaceuticals USA, Inc.
$46
Circassia Pharmaceuticals Inc
$38
Grifols USA, LLC
$38
Advanced Respiratory, Inc
$37
Baxter Healthcare
$34
Bayer HealthCare Pharmaceuticals Inc.
$34
Mallinckrodt LLC
$27
Allergan Inc.
$26
AbbVie Inc.
$24
ABBVIE INC.
$21
Jazz Pharmaceuticals Inc.
$19
Smith+Nephew, Inc.
$16
Electromed, Inc.
$16
Allergan, Inc.
$15
Shire North American Group Inc
$14
Sanofi Pasteur Inc.
$11
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ANORO · AREXVY · AVYCAZ · Adempas · AirFit · Arikayce · Astral · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · DUPIXENT · Esbriet · FASENRA · FLUZONE HIGH-DOSE · GATTEX · GLASSIA · HYQVIA · Haegarda · Hillrom - Life 2000 Ventilation System · Hizentra · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PICO 7 Single Use Negative Pressure Wound Therapy · Perforomist · Prolastin-C Liquid · QVAR · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAVNEOS · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Veklury · WAKIX · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
9
Per 100K population
2.2
County median income
$60,673
Nearest hospital
ASCENSION GENESYS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Al-Ali is a mixed practice specialist, with above-average Medicare volume (top 7% in MI), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Ali experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Al-Ali performed 817 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Al-Ali receive payments from pharmaceutical companies?
Yes. Dr. Al-Ali received a total of $4,940 from 39 companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Al-Ali's costs compare to other critical care medicines in Grand Blanc?
Dr. Al-Ali's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Al-Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Grand Blanc
Browse critical care medicines in Grand Blanc ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in MI
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in MI
Which MI critical care medicines receive the most from drug and device companies.
By company
Pulmonx Corporation Payments to Doctors
See all physicians who received payments from Pulmonx Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology